M.D. Anderson Cancer Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, M.D. Anderson Cancer Center sits in the top decile of US sponsors by registered trial count (#3 of 15,751 sponsors by registered trial count).

2,692 total trials 549 currently recruiting 1201 completed early-phase tilt top decile by trial count

M.D. Anderson Cancer Center: 2,692 sponsored US clinical trials, 549 recruiting.

M.D. Anderson Cancer Center sponsors 2,692 registered US clinical trials on ClinicalTrials.gov, 549 of them currently recruiting, and 1,201 completed. 124 of these trials are in Phase 3-4 (later-stage) and 1,719 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hematopoietic and Lymphoid Cell Neoplasm, with 44 trials.

Top-decile sponsor footprint

M.D. Anderson Cancer Center ranks in the top decile of sponsors by registered trial count (#3 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

2,692 total, page 43 of 54

COMPLETED

A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy

NCT00539227
COMPLETED Phase 1

Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)

NCT00542971
TERMINATED Phase 2

Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma

NCT00561912
TERMINATED Phase 2

Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma

NCT00539500
TERMINATED Phase 2

Haelan and Nutrition in Cancer Patients

NCT00558558
TERMINATED

Cardiac Biomarkers in Early Detection of Cardiotoxicity in Patients Receiving Sunitinib or Sorafenib Chemotherapy

NCT00532064
COMPLETED

Neuropathic Pain in Survivors of Breast Cancer

NCT00535067
COMPLETED Phase 3

Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery

NCT00542542
COMPLETED Phase 2

Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

NCT00536978
COMPLETED Phase 1

Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease

NCT00543777
TERMINATED Phase 1

ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma

NCT00533169
COMPLETED Phase 2

3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy

NCT00520702
COMPLETED Phase 2

4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Thoracic Malignancies

NCT00531180
COMPLETED

Perceptions of Cervical Cancer Among Asian Americans

NCT00518388
COMPLETED

The Exceptional Patient in Cancer Care

NCT00543153
COMPLETED NA

Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)

NCT00525655
COMPLETED

Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System

NCT00837993
COMPLETED Phase 1

Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer

NCT00529022
COMPLETED Phase 1

Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

NCT00521859
COMPLETED Phase 1

Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes

NCT00493571
COMPLETED Phase 4

Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy

NCT00526331
TERMINATED Phase 2

Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor

NCT00523809
TERMINATED Phase 1

Doxercalciferol in Recurrent Pediatric Solid Tumors

NCT00511017
COMPLETED Phase 1

Cord Blood Expansion on Mesenchymal Stem Cells

NCT00498316
COMPLETED NA

CHESS: Human and Computer Mentors for Prostate Cancer Patients

NCT00516256
COMPLETED Phase 1

Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases

NCT00513162
COMPLETED Phase 2

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma

NCT00496587
TERMINATED Phase 1

Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)

NCT00480987
TERMINATED Phase 1

Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines

NCT00514189
COMPLETED

Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin

NCT00502177
COMPLETED Phase 1

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

NCT00491855
COMPLETED NA

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

NCT00490282
COMPLETED NA

Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study

NCT00487331
COMPLETED Phase 2

Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer

NCT00506155
COMPLETED Phase 1

Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor

NCT00495872
COMPLETED Phase 2

CEP-701 for PH-negative Myelofibrosis

NCT00494585
COMPLETED

Ovarian Cancer Patient Questionnaire on Genetic Testing

NCT00486707
COMPLETED

Latent Tuberculosis Infection in Cancer Patients

NCT00507754
COMPLETED Phase 2

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

NCT00429182
COMPLETED Phase 1

Valproic Acid and Bevacizumab in Patients With Advanced Cancer

NCT00530907
TERMINATED

Digital Imaging Aid for Assessment of Cervical Dysplasia

NCT00511758
TERMINATED

Urodynamic Evaluation in Post-radiation Salvage Prostatectomy Patients

NCT00901420
COMPLETED

Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia

NCT00503854
COMPLETED NA

Effect of Parathyroidectomy on Sleep

NCT00501215
COMPLETED

Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine

NCT00478686
COMPLETED Phase 3

Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients

NCT00481884
COMPLETED

School Reintegration Outcomes in Pediatric Cancer Patients

NCT00477256
COMPLETED NA

Erwinase Study in Patients With Acute Lymphoblastic Leukemia

NCT00506597
COMPLETED

Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes

NCT00501449
COMPLETED Phase 1

Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias

NCT00472849
← Previous Page 43 of 54 Next →

Phase Distribution

PhaseTrial count
Phase 1 748
Phase 2 971
Phase 3 96
Phase 4 28

Therapeutic Areas

Hematopoietic and Lymphoid Cell Neoplasm 44
Malignant Solid Neoplasm 42
Breast Cancer 41
Acute Myeloid Leukemia 38
Leukemia 37
Myelodysplastic Syndrome 33
Lymphoma 32
Cancer 31
Recurrent Acute Myeloid Leukemia 25
Lung Cancer 23

What is open in the M.D. Anderson Cancer Center pipeline

549 recruiting of 2,692 indexed (20% open); 1,201 completed (45%).

Phase mix: 124 late (III/IV) vs 1,719 early (I/II) (early-phase heavy).

Top condition: Hematopoietic and Lymphoid Cell Neoplasm (44 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.